SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-08-000135
Filing Date
2008-02-14
Accepted
2008-02-14 10:40:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT AMENDMENT prx0208a1.txt SC 13G/A 10981
  Complete submission text file 0001172661-08-000135.txt   12952
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46121 | Film No.: 08609482
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017
Business Address 767 3RD AVENUE 30TH FLOOR NEW YORK NY 10017 2126845700
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A